MNBRX
Price
$19.48
Change
-$0.09 (-0.46%)
Updated
Jun 22 closing price
Net Assets
368.81M
RLEFX
Price
$40.73
Change
-$0.14 (-0.34%)
Updated
Jun 22 closing price
Net Assets
287.61B
Interact to see
Advertisement

MNBRX vs RLEFX

MNBRX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
MNBRX vs. RLEFX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNBRX is a Buy and RLEFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 288B vs. MNBRX (369M). RLEFX pays higher dividends than MNBRX: RLEFX (1.94) vs MNBRX (1.42). MNBRX was incepted earlier than RLEFX: MNBRX (16 years) vs RLEFX (11 years). MNBRX (1.28) is less costly to investors than RLEFX (0.39). MNBRX is a more actively managed with annual turnover of: 78.00 vs. RLEFX (50.00). RLEFX has a lower initial minimum investment than MNBRX: RLEFX (250) vs MNBRX (2000). RLEFX annual gain was more profitable for investors over the last year : 16.92 vs. MNBRX (0.49). RLEFX return over 5 years is better than : 37.16 vs. MNBRX (-7.11).
MNBRXRLEFXMNBRX / RLEFX
Total Expense Ratio1.280.39328%
Annual Report Gross Expense Ratio1.280.39328%
Fund Existence16 years11 years-
Gain YTD1.6629.45718%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets369M288B0%
Annual Yield % from dividends1.421.9473%
Returns for 1 year0.4916.923%
Returns for 3 years13.2245.1229%
Returns for 5 years-7.1137.16-19%
Returns for 10 years9.7992.2011%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDY13.910.62
+4.67%
Dr. Reddy's Laboratories Ltd
EPRX6.650.17
+2.62%
Eupraxia Pharmaceuticals
NEWTP24.890.07
+0.27%
NewtekOne Inc.
CING4.94-0.05
-1.00%
Cingulate Inc
BRZE19.21-0.85
-4.24%
Braze